Dr. Emily Greengard
Claim this profileUniversity of Minnesota/Masonic Cancer Center
Expert in Tumors
Expert in Neuroblastoma
45 reported clinical trials
71 drugs studied
About Emily Greengard
Education:
- Earned an MD from Saint Louis University School of Medicine in 2004.
Experience:
- Completed a Residency in Pediatrics at Children's Memorial Hospital, Chicago, IL, in 2007.
- Finished a Fellowship in Pediatric Hematology-Oncology at Children's Hospital of Philadelphia in 2010.
- Served as an Instructor in Pediatrics at the University of Pennsylvania School of Medicine (2007-2010).
- Currently an Associate Professor of Pediatrics in the Division of Hematology/Oncology at the University of Minnesota and Fellowship Program Director for Pediatric Hematology/Oncology.
Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Neuroblastoma
Global LeaderStage IV
MYC positive
MYC negative
Affiliated Hospitals
Clinical Trials Emily Greengard is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This study is evaluating whether genetic testing may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
CBL0137
for Cancer
This phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous system (CNS) tumors or lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Drugs, such as CBL0137, block signals passed from one molecule to another inside a cell. Blocking these signals can affect many functions of the cell, including cell division and cell death, and may kill cancer cells.
Recruiting1 award Phase 1 & 213 criteria
More about Emily Greengard
Clinical Trial Related4 years of experience running clinical trials · Led 45 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Emily Greengard has experience with
- Cyclophosphamide
- Ramucirumab
- Vinorelbine
- Irinotecan
- Temozolomide
- Carboplatin
Breakdown of trials Emily Greengard has run
Tumors
Neuroblastoma
Recurrence
Osteosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Greengard specialize in?
Emily Greengard focuses on Tumors and Neuroblastoma. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage I.
Is Emily Greengard currently recruiting for clinical trials?
Yes, Emily Greengard is currently recruiting for 15 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Emily Greengard has studied deeply?
Yes, Emily Greengard has studied treatments such as Cyclophosphamide, Ramucirumab, Vinorelbine.
What is the best way to schedule an appointment with Emily Greengard?
Apply for one of the trials that Emily Greengard is conducting.
What is the office address of Emily Greengard?
The office of Emily Greengard is located at: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota 55455 United States. This is the address for their practice at the University of Minnesota/Masonic Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.